NEW YORK ( The Deal) -- Barcelona drugmaker Grifols (GRFS - Get Report) on Monday, Nov. 11, went shopping in California for a second time this year, picking up the Emeryville-based blood transfusion diagnostics business of Swiss drug company Novartis (NVS - Get Report).Grifols would pay $1.68 billion for the unit, which makes equipment and chemicals for screening donated blood for infectious diseases. The division had sales last year of $565 million.
Grifols Buys Novartis' Transfusion Diagnostics Business
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.